An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance†‡
Abstract
Synthetic riboswitch containing aptamer is constructed in E. coli to regulate the expression of β-lactamase through small molecule–aptamer interactions, which sharply reduces the